Pt Kimia Farma Persero Tbk operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pt Kimia Farma Persero Tbk with three other
pharmaceutical manufacturers in Asia:
Shijiazhuang Yiling Pharmaceutical Co Ltd
of China
(2012
sales of 1.65 billion Chinese Renmimbi [US$268.26 million]
),
ChangChun High New Technology Industries
of China
(1.74 billion Chinese Renmimbi [US$283.66 million]
of which 83%
was Pharmaceutical Industry), and
Guizhou Yibai Pharmaceutical Co., Ltd.
which is
also
based in China
(2.25 billion Chinese Renmimbi [US$366.52 million]
of which 82%
was Prescription Medicine).
Sales Analysis.
Pt Kimia Farma Persero Tbk reported sales of 3.73 trillion Indonesian Rupiahs (US$384.63 million)
for the
year ending
December of 2012.
This
represents
an
increase of 7.3%
versus 2011, when the company's sales were 3.48 trillion Indonesian Rupiahs.
Sales at Pt Kimia Farma Persero Tbk have increased during each of the previous five years
(and since 2007, sales have increased a total of 58%).
Business Description